These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 21251543)

  • 1. Hypertension after kidney transplant.
    Mangray M; Vella JP
    Am J Kidney Dis; 2011 Feb; 57(2):331-41. PubMed ID: 21251543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension, living kidney donors, and transplantation: where are we today?
    Rossi AP; Vella JP
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):154-64. PubMed ID: 25704353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial hypertension in renal transplant recipients].
    Basić-Jukić N; Jurić I; Kes P; Bubić-Filipi L; Brunetta B; Pasini J
    Acta Med Croatica; 2007 Apr; 61(2):171-6. PubMed ID: 17585473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in kidney transplant recipients.
    Ponticelli C; Cucchiari D; Graziani G
    Transpl Int; 2011 Jun; 24(6):523-33. PubMed ID: 21382101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
    Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-transplant nephropathy and arterial hypertension].
    Oko A; Idasiak-Piechocka I; Czekalski S
    Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients.
    Steigerwalt SP; Brar N; Dhungel A; Butcher D; Steigerwalt S; El-Ghouroury M; Provenzano R
    Transplant Proc; 2009 Dec; 41(10):4184-7. PubMed ID: 20005365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in kidney transplantation.
    Castillo-Lugo JA; Vergne-Marini P
    Semin Nephrol; 2005 Jul; 25(4):252-60. PubMed ID: 16202698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does antihypertensive therapy modify chronic allograft failure?
    Raine AE
    Kidney Int Suppl; 1995 Dec; 52():S107-11. PubMed ID: 8587270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.
    Formica RN; Friedman AL; Lorber MI; Smith JD; Eisen T; Bia MJ
    Nephrol Dial Transplant; 2006 May; 21(5):1389-94. PubMed ID: 16431893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic disorders in renal transplant recipients].
    Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure control in orthotopic heart transplant and kidney allograft recipients is far from satisfactory.
    Przybylowski P; Malyszko J; Malyszko JS; Kobus G; Sadowski J; Mysliwiec M
    Transplant Proc; 2010 Dec; 42(10):4263-6. PubMed ID: 21168679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control in kidney transplantation: therapeutic implications.
    Premasathian NC; Muehrer R; Brazy PC; Pirsch JD; Becker BN
    J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients.
    Divac N; Naumović R; Stojanović R; Prostran M
    Curr Med Chem; 2016; 23(19):1941-52. PubMed ID: 26687832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure control according to the prevalence of diabetes in renal transplant recipients.
    Zbroch E; Malyszko J; Glowinska I; Maciorkowska D; Kobus G; Mysliwiec M
    Transplant Proc; 2013; 45(1):200-4. PubMed ID: 23375300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cyclosporine induced hypertension: Results from a long-term observational study using different antihypertensive medications.
    Marienhagen K; Lehner F; Klempnauer J; Hecker H; Borlak J
    Vascul Pharmacol; 2019 Apr; 115():69-83. PubMed ID: 29933079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.